80
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Anti-insulin-like growth factor-IIP3 DNAzymes inhibit cell proliferation and induce caspase-dependent apoptosis in human hepatocarcinoma cell lines

, &
Pages 1089-1102 | Published online: 04 Oct 2013

References

  • El-Serag HB Hepatocellular carcinoma N Engl J Med 2011 365 12 1118 1127 21992124
  • Ferlay J Shin HR Bray F Forman D Mathers C Parkin DM GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No 10 Lyon, France International Agency for Research on Cancer Available from: http://globocan.iarc.fr Accessed May 12, 2013
  • Cabibbo G Latteri F Antonucci M Craxi A Multimodal approaches to the treatment of hepatocellular carcinoma Nat Clin Pract Gastroenterol Hepatol 2009 6 3 159 169 19190599
  • Marrero JA Kudo M Bronowicki JP The challenge of prognosis and staging for hepatocellular carcinoma Oncologist 2010 15 Suppl 4 23 33 21115578
  • Chen PJ Furuse J Han KH Issues and controversies of hepatocellular carcinoma-targeted therapy clinical trials in Asia: experts’ opinion Liver Int 2010 30 10 1427 1438 20557456
  • Wilhelm SM Adnane L Newell P Villanueva A Llovet JM Lynch M Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling Mol Cancer Ther 2008 7 10 3129 3140 18852116
  • Pollak M Insulin and insulin-like growth factor signalling in neoplasia Nat Rev Cancer 2008 8 12 915 928 19029956
  • Breuhahn K Longerich T Schirmacher P Dysregulation of growth factor signaling in human hepatocellular carcinoma Oncogene 2006 25 27 3787 3800 16799620
  • Breuhahn K Schirmacher P Reactivation of the insulin-like growth factor-II signaling pathway in human hepatocellular carcinoma World J Gastroenterol 2008 14 11 1690 1698 18350600
  • Brissenden JE Ullrich A Francke U Human chromosomal mapping of genes for insulin-like growth factors I and II and epidermal growth factor Nature 1984 310 5980 781 784 6382023
  • Chao W D’Amore PA IGF2: epigenetic regulation and role in development and disease Cytokine Growth Factor Rev 2008 19 2 111 120 18308616
  • Qian B Katsaros D Lu L IGF-II promoter specific methylation and expression in epithelial ovarian cancer and their associations with disease characteristics Oncol Rep 2011 25 1 203 213 21109978
  • Vernucci M Cerrato F Besnard N The H19 endodermal enhancer is required for Igf2 activation and tumor formation in experimental liver carcinogenesis Oncogene 2000 19 54 6376 6385 11175353
  • Uchida K Kondo M Takeda S Osada H Takahashi T Nakao A Altered transcriptional regulation of the insulin-like growth factor 2 gene in human hepatocellular carcinoma Mol Carcinog 1997 18 4 193 198 9142213
  • McManus SA Li Y The structural diversity of deoxyribozymes Molecules 2010 15 9 6269 6284 20877222
  • Schlosser K Li Y Biologically inspired synthetic enzymes made from DNA Chem Biol 2009 16 3 311 322 19318212
  • He J Zhang D Wang Q Wei X Cheng M Liu K A novel strategy of chemical modification for rate enhancement of 10–23 DNAzyme: a combination of A9 position and 8-aza-7-deaza-2′-deoxyadenosine analogs Org Biomol Chem 2011 9 16 5728 5736 21717014
  • Wang F Elbaz J Orbach R Magen N Willner I Amplified analysis of DNA by the autonomous assembly of polymers consisting of DNAzyme wires J Am Chem Soc 2011 133 43 17149 17151 21954996
  • Teng B Xin D Wen L Cui S Jin C Research of 10–23 DNAZyme inhibit the expression of eIF4E genes Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2007 21 12 552 554 Chinese 17802829
  • Verma N Tripathi SK Chaudhury I Das HR Das RH iNOS-targeted 10–23 DNAzyme reduces LPS-induced systemic inflammation and mortality in mice Shock 2010 33 5 493 499 19823115
  • Wang TH Li WT Yu SH Au LC The use of 10–23 DNAzyme to selectively destroy the allele of mRNA with a unique purine-pyrimidine dinucleotide Oligonucleotides 2008 18 3 295 299 18699741
  • Kong DM Xu J Shen HX Positive effects of ATP on G-quadruplex-hemin DNAzyme-mediated reactions Anal Chem 2010 82 14 6148 6153 20552961
  • Zhang M Zhao H Luo F Luo S Shi W IGF-II inhibitory DNAzymes inhibit the invasion and migration of hepatocarcinoma cells Biotechnol Lett 2011 33 5 911 917 21267763
  • Dass CR Tan ML Galloway SJ Choong PF Dz13 induces a cytotoxic stress response with upregulation of E2F1 in tumor cells metastasizing to or from bone Oligonucleotides 2010 20 2 79 91 20406096
  • Yu SH Wang TH Au LC Specific repression of mutant K-RAS by 10–23 DNAzyme: sensitizing cancer cell to anti-cancer therapies Biochem Biophys Res Commun 2009 378 2 230 234 19014906
  • Mosmann T Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J Immunol Methods 1983 65 1–2 55 63 6606682
  • Zhou H Tang Y Liang X RNAi targeting urokinase-type plasminogen activator receptor inhibits metastasis and progression of oral squamous cell carcinoma in vivo Int J Cancer 2009 125 2 453 462 19391133
  • Crawford ED Wells JA Caspase substrates and cellular remodeling Annu Rev Biochem 2011 80 1055 1087 21456965
  • Riedl SJ Salvesen GS The apoptosome: signalling platform of cell death Nat Rev Mol Cell Biol 2007 8 5 405 413 17377525
  • Taylor RC Cullen SP Martin SJ Apoptosis: controlled demolition at the cellular level Nat Rev Mol Cell Biol 2008 9 3 231 241 18073771
  • Liu GN Teng YX Yan W Transfected synthetic DNA enzyme gene specifically inhibits Egr-1 gene expression and reduces neointimal hyperplasia following balloon injury in rats Int J Cardiol 2008 129 1 118 124 18242730
  • Zhou J Yang XQ Xie YY Inhibition of respiratory syncytial virus of subgroups A and B using deoxyribozyme DZ1133 in mice Virus Res 2007 130 1–2 241 248 17804108
  • Hallett MA Teng B Hasegawa H Schwab LP Seagroves TN Pourmotabbed T Anti-matrix metalloproteinase-9 DNAzyme decreases tumor growth in the MMTV-PyMT mouse model of breast cancer Breast Cancer Res 2013 15 1 R12 23407024
  • Kosman J Juskowiak B Peroxidase-mimicking DNAzymes for biosensing applications: a review Anal Chim Acta 2011 707 1–2 7 17 22027115
  • Qiu LW Yao DF Zong L Abnormal expression of insulin-like growth factor-II and its dynamic quantitative analysis at different stages of hepatocellular carcinoma development Hepatobiliary Pancreat Dis Int 2008 7 4 406 411 18693177
  • Rockwell P O’Connor WJ King K Goldstein NI Zhang LM Stein CA Cell-surface perturbations of the epidermal growth factor and vascular endothelial growth factor receptors by phosphorothioate oligodeoxynucleotides Proc Natl Acad Sci U S A 1997 94 12 6523 6528 9177251
  • Wahlestedt C Salmi P Good L Potent and nontoxic antisense oligonucleotides containing locked nucleic acids Proc Natl Acad Sci U S A 2000 97 10 5633 5638 10805816
  • Fluiter K ten Asbroek AL de Wissel MB In vivo tumor growth inhibition and biodistribution studies of locked nucleic acid (LNA) antisense oligonucleotides Nucleic Acids Res 2003 31 3 953 962 12560491
  • Dass CR Galloway SJ Choong PF Dz13, a c-jun DNAzyme, is a potent inducer of caspase-2 activation Oligonucleotides 2010 20 3 137 146 20180631
  • Wu Y Yu L McMahon R Rossi JJ Forman SJ Snyder DS Inhibition of bcr-abl oncogene expression by novel deoxyribozymes (DNAzymes) Hum Gene Ther 1999 10 17 2847 2857 10584930
  • Liang Z Wei S Guan J DNAzyme-mediated cleavage of survivin mRNA and inhibition of the growth of PANC-1 cells J Gastroenterol Hepatol 2005 20 10 1595 1602 16174080
  • Tang SH Yang DH Huang W Zhou HK Lu XH Ye G Hypomethylated P4 promoter induces expression of the insulin-like growth factor-II gene in hepatocellular carcinoma in a Chinese population Clin Cancer Res 2006 12 14 Pt 1 4171 4177 16857788
  • Kiss A Wang NJ Xie JP Thorgeirsson SS Analysis of transforming growth factor (TGF)-alpha/epidermal growth factor receptor, hepatocyte growth Factor/c-met, TGF-beta receptor type II, and p53 expression in human hepatocellular carcinomas Clin Cancer Res 1997 3 7 1059 1066 9815784
  • Merle P de la Monte S Kim M Functional consequences of frizzled-7 receptor overexpression in human hepatocellular carcinoma Gastroenterolog y 2004 127 4 1110 1122
  • Veronese A Lupini L Consiglio J Oncogenic role of miR-483-3p at the IGF2/483 locus Cancer Res 2010 70 8 3140 3149 20388800
  • Callegari E Elamin BK Giannone F Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model Hepatology 2012 56 3 1025 1033 22473819